Arizona Bioscience News: Dignity Health heart disease study; Tucson cancer-drug firm acquired; Phoenix Biomedical Campus to add two towers

February 25, 2022

By brianpowell

An Arizona study will use DNA testing to determine risk of heart disease / KJZZ

Dignity Health is launching the first study of its kind in North America that will use DNA to determine a person’s risk of heart disease. Read more: Dignity Health launches groundbreaking study to combat heart disease

Tucson cancer-drug startup acquired by Minneapolis firm / Arizona Daily Star

Cancer Prevention Pharmaceuticals, which is developing drugs designed to reduce the risk of cancer and other diseases based on technology developed partly at the University of Arizona, is being acquired by Panbela Therapeutics Inc. for up to $60 million.

Twin office towers planned for downtown Phoenix bioscience campus / Phoenix Business Journal

A partnership between Wexford Science and Technology, Arizona State University, and the city of Phoenix plans to build the next structure on the downtown Phoenix Biomedical Campus, known as 843 PBC, that will encompass two towers that could end up totaling 600,000 square feet.

7 Arizona bioscience startups to watch in 2022 / AZ Big Media

The Flinn Foundation has selected seven Arizona-based, early-stage bioscience companies for its 2022 Bioscience Entrepreneurship Program which provides $30,000 in funding support through a nonprofit partner, a personalized learning plan, and connections with the state’s bioscience leaders.

University of Arizona-backed research is finding the source for feelings of hunger / Arizona Public Media

University of Arizona researchers are looking at the neural circuitry in the amygdala, the part of the brain that also controls fear, pain, and other strong emotions, as they narrow down the search for what causes us to feel hungry.

UArizona researchers develop AI-driven method for diagnosing lung disease / AZ Big Media

Researchers at the University of Arizona College of Medicine-Tucson have developed a new way to provide earlier diagnosis of lung disease that involves analyzing metabolites.

Arizona flu cases lower than pre-COVID numbers for 2nd straight year / KJZZ

Flu cases in Arizona are dramatically down compared to pre-COVID-19 numbers for the second year in a row, with just 5,126 cases through Feb. 12.

Arizona-grown CSO Program goes global to transform students into STEM ambassadors / Phoenix Business Journal (Op-ed)

Arizona’s Chief Science Officer program, launched in 2015 by the SciTech Institute in partnership with the Arizona Commerce Authority and Arizona Technology Council, is a global model for fueling the next generation of science and technology professionals.

Listening to plants / The Lab at azcentral

In the second podcast about talking to plants, listeners will go to a desert farm field and a humid rainforest that are both in Arizona.

Upcoming Events

March 1: A Sip of Science: Sequencing SARS-CoV-2 variants

March 2-3: Venture Madness

Sign up to receive Arizona Bioscience News weekly

Search the Arizona BioMap